Chatbot for young people with type 1 diabetes mellitus

The development of a chatbot to support successful transition to adult care of young people with type 1 diabetes mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15525627

Enrollment

249

Registered

2022-02-15

Start date

2021-06-01

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes Nutritional, Metabolic, Endocrine Type 1 diabetes mellitus

Interventions

This registration focuses on Work Package 7, however all the WPs are described for background information. We will deliver our four objectives across one pre-development phase and eight work packages

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 11 - 25 years 2. Diagnosed with type 1 diabetes mellitus (T1DM) 3. Cared for by the Diabetes Clinical Teams at one of four NHS sites (Sheffield Children's Hospital, Leeds Children's Hospital, Royal Liverpool University Hospital, University Hospitals Birmingham) 4. Fluent in spoken English 5. Familiar with using a PC, smartphone, or tablet (DigiBete operates on 96% of mobile phones supporting apps up to Android 7 and IOS from iPhone 6. (For YP who do not have access to any of these devices we will provide them with the equipment to support their involvement with the trial.) 6. If in paediatric diabetes services: expected to transfer to adult NHS diabetes service 7. If in adult diabetes services: transferred from a paediatric NHS diabetes services 8. The exact inclusion criteria for digitally and socially excluded YP will be determined by the scoping review currently being undertaken by mHabitat

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Secondary

Measure	Time frame
At baseline, 2 weeks and 6 weeks: 1. Anxiety and Depression measured using The Hospital Anxiety and Depression Scale (HADS) 2. Health-Related Quality of Life measured using The Short-Form 36 (SF-36) 3. Young people’s, parent/carers’, and health professionals’ experiences and perspectives will be measured using qualitative focus groups and interviews at the end of the study. We will use Framework to analyse qualitative data; Framework is a systematic method for handling large qualitative data sets by iterating between: collecting data, identifying themes, coding/labelling data, identifying categories, and possible interpretations. Constant comparison of data, supplemented by regular project management group discussions, will open up meaning.	—

Measure

Time frame

At baseline, 2 weeks and 6 weeks: 1. Anxiety and Depression measured using The Hospital Anxiety and Depression Scale (HADS) 2. Health-Related Quality of Life measured using The Short-Form 36 (SF-36) 3. Young people’s, parent/carers’, and health professionals’ experiences and perspectives will be measured using qualitative focus groups and interviews at the end of the study. We will use Framework to analyse qualitative data; Framework is a systematic method for handling large qualitative data sets by iterating between: collecting data, identifying themes, coding/labelling data, identifying categories, and possible interpretations. Constant comparison of data, supplemented by regular project management group discussions, will open up meaning.

—

Primary

Measure	Time frame
At baseline, 2 weeks and 6 weeks: 1. Usability measured using The System Usability Scale (SUS) 2. Acceptability measured using The Mobile App Rating Scale (MARS)	—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026